Sugi Predict

Sugi Predict / Compounds / SCHEMBL19679355

SCHEMBL19679355

SCHEMBL19679355

C[C@@H]1CN(C(=O)OC(C)(C)C)C(=O)c2c(OCc3ccccc3)cccc2O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ GRM2 Q14416 1/20 0.39
▸ PRKCA P17252 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ CREBBP Q92793 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ GPR119 Q8TDV5 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ TLR9 Q9NR96 2/20 0.36
▸ TLR7 Q9NYK1 2/20 0.36
▸ GHSR Q92847 2/20 0.36
▸ FABP5 Q01469 1/20 0.36
▸ KLK7 P49862 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19684748 0.85 PRKCA (0.36) PRKCAMAPT
SCHEMBL19667585 0.80 GPR119 (0.42) GRM2AKR1B1NPC1RAB9ASMN1; SMN2
SCHEMBL19667626 0.79 BRD4 (0.41) MAOAMAOBPRKCABRD4CREBBP
SCHEMBL30207816 0.78 KDM1A (0.41) GPR119TLR9TLR7KLK7
SCHEMBL19667181 0.78 KDM1A (0.41) GPR119TLR9TLR7KLK7
SCHEMBL19667625 0.73 MAOA (0.40) MAOAMAOBPRKCABRD4CREBBP
SCHEMBL19667164 0.72 TLR9 (0.38) TLR9TLR7GHSR
SCHEMBL30207906 0.72 TLR9 (0.38) TLR9TLR7GHSR
SCHEMBL19667670 0.72 KLK7 (0.42) GPR119TLR9TLR7GHSRKLK7
SCHEMBL19667443 0.72 GRM5 (0.42) MAPTTLR9TLR7KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464249-B1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER (US) 2021-08-11 — — EP disclosed
US-10709709-B2 Substituted carbonucleoside derivatives useful as anticancer agents PFIZER INC. (US) 2020-07-14 — — US disclosed
US-20190111060-A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2019-04-18 — — US disclosed
US-10220037-B2 Substituted carbonucleoside derivatives useful as anticancer agents PFIZER INC. (US) 2019-03-05 — — US disclosed
US-20170348313-A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2017-12-07 — — US disclosed
US-20170348313-A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10709709-B2 Substituted carbonucleoside derivatives useful as anticancer agents DUT, NCL, TYMP MAOA 3689/4885MAOB 3330/4885GRM2 4704/4885
US-20170348313-A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS DUT, NCL, TYMP MAOA 3689/4885MAOB 3330/4885GRM2 4704/4885
US-20190111060-A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS DUT, NCL, TYMP MAOA 3689/4885MAOB 3330/4885GRM2 4704/4885
US-10220037-B2 Substituted carbonucleoside derivatives useful as anticancer agents DUT, NCL, TYMP MAOA 3689/4885MAOB 3330/4885GRM2 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.